Biofilms: a role in recurrent mastitis infections?

The Veterinary Journal
M B MelchiorJ Fink-Gremmels

Abstract

Mastitis remains one the most important diseases in dairy cattle despite the progress made in improving general udder health in recent years. Epidemiological studies have revealed that following treatment with antimicrobials, bacteriological cure rates vary between 0% and 80% but with no evidence of a significant loss of activity of the major classes of antibiotics licensed for the treatment of bovine mastitis. Recurrent infections are often attributable to biofilm growth of bacteria and this review provides an overview of those mechanisms related to bacterial biofilm growth in mastitis. Biofilm formation is accompanied by significant genetic and subsequent physiological changes in the microorganisms resulting, inter alia, in a loss of sensitivity to virtually all classes of antibiotics.

References

Feb 1, 1991·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R J YanceyC W Ford
Aug 1, 1989·Journal of Clinical Pathology·D J FreemanC T Keane
Oct 1, 1986·Infection and Immunity·G M JohnsonP G Quie
Nov 1, 1996·Antimicrobial Agents and Chemotherapy·P S Stewart
Dec 16, 1998·The Journal of Antimicrobial Chemotherapy·R G FinchG S Stewart
May 21, 1999·Science·J W CostertonE P Greenberg
Aug 25, 1999·The Journal of Antimicrobial Chemotherapy·B AmorenaJ Hernández-Yago
Sep 3, 1999·Applied and Environmental Microbiology·J L Adams, R J McLean
Sep 28, 1999·Journal of Bacteriology·C Prigent-CombaretP Lejeune
Feb 5, 2000·The Journal of Hospital Infection·D Mack
Feb 19, 2000·Antimicrobial Agents and Chemotherapy·A BroounK Lewis
Jun 8, 2000·Journal of Veterinary Medicine. A, Physiology, Pathology, Clinical Medicine·A M Ehinger, M Kietzmann
Jun 30, 2000·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·P WilliamsB W Bycroft
Sep 7, 2000·Microbiology and Molecular Biology Reviews : MMBR·K Lewis
Feb 13, 2001·Trends in Microbiology·T F Mah, G A O'Toole
Feb 15, 2001·Current Opinion in Microbiology·M R GrahamJ M Musser

❮ Previous
Next ❯

Citations

Feb 23, 2013·International Journal of Microbiology·Mark FentonAidan Coffey
Sep 12, 2008·BMC Microbiology·Esther JiménezJuan M Rodríguez
Feb 20, 2010·PloS One·Cira Daniela RinaudoDomenico Maione
Mar 18, 2010·Biofouling·Domenico SchillaciMaria Vitale
May 8, 2013·Canadian Journal of Microbiology·Vitor Oliveira SilvaMaria Aparecida Scatamburlo Moreira
Nov 19, 2011·Tropical Animal Health and Production·Somanath Kundalik ChavhanNitin Vasantrao Kurkure
Mar 6, 2010·Applied Microbiology and Biotechnology·Anna DürigPer Klemm
Oct 26, 2010·Animal Health Research Reviews·Mario JacquesYannick D N Tremblay
Feb 18, 2016·Breastfeeding Medicine : the Official Journal of the Academy of Breastfeeding Medicine·Pamela BerensAlison M Steube
Jan 17, 2016·Pathogens and Disease·Fernanda GomesMariana Henriques
Apr 24, 2012·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Mohamed Elhadidy, Asmaa Elsayyad
Sep 24, 2015·Letters in Applied Microbiology·Jakub Kwiecinski
Oct 24, 2012·European Journal of Medicinal Chemistry·Maria Valeria RaimondiGiuseppe Daidone
Apr 29, 2011·Veterinary Immunology and Immunopathology·Gabriel LeitnerNaomi Balaban
Apr 7, 2016·Veterinary World·Umar Faruk AbdullahiMaryam Ibrahim Umar
Dec 20, 2008·International Journal of Antimicrobial Agents·Jakub KwiecińskiKinga Wójcik
Feb 6, 2007·Veterinary Microbiology·A L ClutterbuckS L Percival
May 12, 2015·Tierärztliche Praxis. Ausgabe G, Grosstiere/Nutztiere·S DegenV Krömker
Jan 24, 2008·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·Steven L PercivalEmma J Woods
Apr 19, 2013·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Mukesh Kumar YadavHo Chul Kim
Jun 1, 2015·Microbial Pathogenesis·Sandra Renata Sampaio SalaberryNilson Roberti Benites
Jul 29, 2015·Veterinary Microbiology·A I GelasakisG C Fthenakis
Jul 30, 2015·Australian Veterinary Journal·J Gogoi-TiwariT K Mukkur
Nov 21, 2014·Animal Science Journal = Nihon Chikusan Gakkaihō·Lívia CastelaniJuliana Rodrigues Pozzi Arcaro

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Cellulitis

Cellulitis (erysipelas) is a recurring and debilitating bacterial infection of the skin and underlying tissue. Discover the latest research on cellulitis here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.